Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Transparency Initiative: GSK's Tailored Comments Seek To Shape Plan

Executive Summary

FDA's transparency initiative has drawn sharp criticism from drug industry organizations fearful that trade secrets will be divulged, but GlaxoSmithKline is taking a different tack in suggesting modifications rather than condemning them outright

You may also be interested in...



Disclosing Drug Development Failures Would Aid Regulatory Science, FDA’s Hamburg Says

FDA is making the case for increased data-sharing and disclosure about drug development failures in the name of bolstering regulatory science.

Disclosing Drug Development Failures Would Aid Regulatory Science, FDA’s Hamburg Says

FDA is making the case for increased data-sharing and disclosure about drug development failures in the name of bolstering regulatory science.

Can FDA Do The "Right Thing" On Transparency? Ask A Lawyer

Proposals from agency task force include releasing when applications are submitted and withdrawn along with FDA reasons for refuse-to-file and complete response letters.

Topics

UsernamePublicRestriction

Register

PS052529

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel